Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

Martee L Hensley, Danielle Enserro, Helen Hatcher, Petronella B Ottevanger, Anders Krarup-Hansen, Jean-Yves Blay, Cyril Fisher, Katherine M Moxley, Shashikant B Lele, Jayanthi S Lea, Krishnansu S Tewari, Premal H Thaker, Oliver Zivanovic, David M O'Malley, Katina Robison, David S Miller